Lee Pharmaceuticals, Inc.

Exited
CIK: 58411•CO•Tier2

Equity (common or preferred stock) · Audited · Manufacturing · SIC 2821

$50M
Qualified
maximum offering price, as qualified
$250K
Reported Sold
1-Z 2023-04-27
7
Filings
across 2 offerings

Equity Classes

TypeClassOutstandingCUSIPPublicly Traded
commonCommon Stock35,162,350524038106OTC Markets Pink Sheets
preferredPreferred A Stock10——

Service Providers

RoleProvider
legalPLLC

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedCommencedPrice/SecuritySecurities OfferedSecurities SoldQualified SoldOutstandingAggregate OfferingProceeds ReportedEstimated NetSupplementsLast Supplement
024-1199152022-09-132023-04-272023-01-172023-01-19$0.015,000,000,00025,000,0005,000,000,00035,162,350$50M$250K$235K22023-01-20

Reporting & Exit

Filed under the issuer’s Regulation A reporting number

File NumberFormFiledSales CommencedSecurities SoldQualified Sold
24R-007821-Z2023-04-272023-01-1925,000,0005,000,000,000

Current Reports

Filing DateFormEventItems
2023-03-231-U/AFundamental Change1,4,7,9.1
2023-03-081-UFundamental Change1,4,7,9.1
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings